IL1B and myeloid sarcoma: In addition to studying VEGF (A and C isoforms were studied separately) and TNF-α, LT-α, IL-6, and IL-10 to refute or validate findings from the pilot cohort, we also analyzed de novo two additional cytokines with putative role in MS, IL-1β, and GM-CSF (33).